The Accure Commitment

Accure is committed to developing a novel and impactful solution for acne sufferers that employs a revolutionary technology designed to improve their long-term quality of life.

Accure is committed to developing a truly differentiated and protected product for clinicians worldwide. Accure’s clinical and technical team is uniquely impressive. The Accure device has been granted CE Mark approval which allows Accure to commercialize in the European Union, while creating a global and exclusive intellectual property portfolio.

Accure is committed to developing a uniquely compelling value proposition. Accure has developed a clear and compelling go-to-market strategy, leveraging significant commercialization experience and regulatory expertise.

Thank you for your interest in Accure!

Christopher Carlton
Chairman, Chief Executive Officer and Co-Founder

A Global Diseaseand Unmet Need

A Solution Aimed At
The Sebaceous Gland

3 - Dermatoendocrinol. 2011 Jan-Mar; 3 (1): 41-49

Read more about The Accure Solution

80% Lesion Reduction in Early Clinical Trials

Accure’s IRB-approved Face Acne Trial demonstrated an average lesion reduction of 80% when measured a full three months after treatments.4




4 - “Tanghetti, E., Geronemus, R., Bloom, B., Anderson, R.R., Ross, E.V., Sakamoto, F.W. Safety And Efficacy Data In A Pilot Study Of The Treatment Of Acne With A Fiber Laser. Poster accepted for presentation at: 40th ASLMS Annual Conference; 2020 April 29 - May 3; Phoenix, AZ, USA."

Our Record of Achievements

An Extraordinary Leadership Team

Accure’s leadership team has domain expertise and significant global experience in commercializing medical devices.

In addition, Accure has curated a world-class team of clinical and technical experts, many of whom are the world’s most experienced and respected partners, collaborators, and clinical researchers.

A co-founder of Accure, Dr. Rox Anderson, has had a profound global impact in healthcare. Dr. Anderson's pivotal "Theory of Selective Photothermolysis" became the basis for the laser hair removal industry, the laser tattoo removal industry, cryolipolysis, and a number of other applications.

Accure’s Principal Investigators are highly respected and world-renowned.

Meet The Team

By targeting the sebaceous gland, Accure is committed to developing a novel solution designed to deliver a long-term benefit to acne sufferers around the world.

Reach out to us today!